Operating review
As this will be my last operating
review as Chief Executive of Porvair before I retire, I hope
shareholders will forgive me if, before reviewing 2024, I comment
on the Group's performance over the last 20 years. In 2001,
the Board decided on a radical change of strategic direction and
undertook a series of disposals. 2004 was the first full year
of trading as a specialist filtration and environmental technology
group, and our strategy has remained unchanged since
then.
Over 20 years, a period including
two recessions and a pandemic:
· Compound revenue growth has been 8%;
· Compound growth in adjusted earnings per share has been 13%;
and
· The
total number of shares at issue has grown by less than 1% per
year.
Shareholders will decide for
themselves how they rate this performance. They are delivered
through the confluence of well-engineered, regularly updated
products; customers and markets supported by secular growth trends;
and a group of outstanding people with whom I have been privileged
to work for two decades. These three remain the cornerstones
of the Group. Over this period Porvair has grown to now
generate around £15 million of surplus cash per year after meeting
its tax, dividend and pension liabilities. This is a solid
basis for further compounding growth. Looking ahead and as
outlined below, near-term opportunities are apparent across the
Group. Longer term, with a new executive management team the
future is bright and I have no doubt the best is yet to
come.
Returning now to near-term trading,
2024 was a year of record revenues and profits, again achieved
despite variable demand patterns across our markets. As
expected, financial performance was better in the second
half.
Aerospace and petrochemical markets
remained robust through the year while industrial consumable orders
remained patchy. Laboratory product demand was consistent,
albeit still at levels below those seen in 2022.
Revenue growth was 9%, 13% on a
constant currency basis (see note 1). Operating profit was up
8% and includes a £0.9 million charge for damage remediation caused
by Hurricane Helene in North Carolina. Strong cash generation
meant that the year finished with £13.7 million of net cash on the
balance sheet (2023: £14.1 million) after spending around £20
million on acquisitions, capital expenditure, dividends and pension
costs.
Porvair's devolved management
structure is helpful in volatile trading conditions, enabling key
commercial decisions to be made closer to customers and suppliers.
Annual objectives for general managers were again to deliver
earnings growth, cash generation and improvements in selected ESG
metrics. Details of our ESG programme are set out in a
separate report published alongside these financial
results.
In common with most filtration
companies, the Group has a diverse operating spread, manufacturing
over 4,000 products and shipping to over 15,000 customers.
The benefit of this is shown in the relatively consistent
financial results of recent years, despite inconsistent demand
across sectors. We serve a range of markets in various parts
of the world and trading is affected by both local and global
events. However, Porvair's underlying growth drivers did not
change in 2024: tightening environmental regulation; the growth of
analytical science; the need for clean water; the development of
carbon-efficient transportation; the replacement of plastic and
steel by aluminium; and the drive for manufacturing process quality
and efficiency.
Financial results
|
2024
|
|
2023
|
|
Growth
|
|
£m
|
|
£m
|
|
%
|
Revenue
|
192.6
|
|
176.0
|
|
9
|
Operating profit
|
22.8
|
|
21.2
|
|
8
|
Adjusted operating profit*
|
24.5
|
|
22.6
|
|
8
|
Profit before tax
|
20.9
|
|
20.1
|
|
4
|
Adjusted profit before
tax*
|
22.7
|
|
21.4
|
|
6
|
|
|
|
|
|
|
|
Pence
|
|
Pence
|
|
|
Earnings per share
|
35.8
|
|
34.8
|
|
3
|
Adjusted earnings per
share*
|
38.6
|
|
37.2
|
|
4
|
|
|
|
|
|
|
|
£m
|
|
£m
|
|
|
Cash generated from
operations
|
25.7
|
|
24.1
|
|
|
Cash and cash equivalents
|
13.7
|
|
14.1
|
|
|
* See notes 1, 2 and 3 for
definitions and reconciliations.
Revenue increased by 9% to £192.6
million (2023: 2% to £176.0 million). Profit before tax
increased by 4% (2023: 7%). Adjusted profit before tax grew
by 6% (2023: 10%) and adjusted earnings per share by 4% (2023:
12%).
Strategy and purpose
Porvair's strategy and purpose have
remained consistent for over 20 years, a period that now
encompasses two recessions and a pandemic. The Group's record for growth, cash generation and
investment is:
|
5 years
|
10 years
|
15 years
|
20 years
|
Revenue CAGR*
|
6%
|
6%
|
9%
|
8%
|
Earnings per share CAGR*
|
9%
|
10%
|
23%
|
12%
|
Adjusted earnings per share
CAGR*
|
9%
|
10%
|
19%
|
13%
|
* Compound annual growth
rate
|
|
|
|
|
|
5 years
|
10 years
|
15 years
|
20 years
|
|
£m
|
£m
|
£m
|
£m
|
Cash from operations
|
104.5
|
175.5
|
227.3
|
250.1
|
Investment in acquisitions and
capital expenditure
|
51.3
|
102.1
|
120.7
|
141.6
|
This longer-term growth record gives
the Board confidence in the Group's capabilities and is the basis
for capital allocation and planning decisions.
Strategic statement and business model
Porvair's strategic purpose
is the development of specialist
filtration, laboratory and environmental technology businesses for
the benefit of all stakeholders. Principal measures of
success include consistent earnings growth and selected ESG
measures as set out in the Group's ESG report.
The Group is positioned to benefit
from global trends as outlined above.
Porvair businesses have certain key
characteristics in common:
· specialist design, engineering or commercial skills are
required;
· product use and replacement is mandated by regulation, quality
accreditation or a maintenance cycle; and
· products are typically designed into a system that will have a
long life-cycle and must perform to a given
specification.
Orders are won by offering the best
technical solutions or commercial service at an acceptable
cost. Technical expertise is necessary in all markets served.
New products are often adaptations of existing designs with
attributes validated in our own test and measurement laboratories.
Experience in specific markets and applications is valuable in
building customer confidence. Domain knowledge is important,
as is deciding where to direct resources.
This leads the Group to:
· focus
on markets with long-term growth potential;
· look
for applications where product use is mandated and replacement
demand is regular;
· make
new product development a core business activity;
· establish geographic presence where end-markets require;
and
· invest
in both organic and acquired growth.
Therefore:
· we
focus on three operating segments: Aerospace & Industrial;
Laboratory; and Metal Melt Quality. All have clear long-term growth
drivers;
· our
products typically reduce emissions or protect complex downstream
systems and, as a result, are replaced regularly. A high
proportion of our annual revenue is from repeat orders;
· through a focus on new product development, we aim to generate
growth rates in excess of the underlying market. Where
possible, we build intellectual property around our product
developments;
· our
geographic presence follows the markets we serve. In the last
twelve months: 44%
of revenue was in the Americas; 16% in Asia; 28% in Continental Europe;
11% in the UK; and
1% in Africa. The
Group has plants in the US, UK, Belgium, Germany, Hungary, the
Netherlands, India and China. In the last twelve
months: 45% of
revenue was manufactured in the US; 27% in the UK; 25% in Continental Europe; and
3% in Asia; and
· we aim
to meet dividend and investment needs from free cash flow and
modest borrowing facilities. In recent years we have expanded
manufacturing capacity in the US, UK, Germany, Hungary and China,
and made several acquisitions. All investments are subject to
a hurdle rate analysis based on strategic and financial
priorities.
Environmental, Social and Governance ("ESG")
The Board understands that
responsible business development is essential for creating
long-term value for stakeholders. Most of the products made
by Porvair are used to the benefit of the environment. Our
water analysis equipment measures contamination levels in
water. Industrial filters are typically needed to reduce
emissions or improve efficiency. Aerospace filters improve safety
and reliability. Nuclear filters confine fissile
materials. Metal Melt Quality filters reduce waste and help
improve the strength to weight ratio of metal
components.
A full ESG report is published at
the time of this results announcement, setting out:
· Porvair's ESG management framework and goals;
· how
energy transition and climate change might affect markets served by
the Group, and how these trends affect our long-term planning
framework;
· ESG
metrics and results; and
· how
the Group has acted for the benefit of its stakeholders in
2024.
Divisional review
Aerospace & Industrial
|
2024
|
|
2023
|
|
Growth
|
|
£m
|
|
£m
|
|
%
|
Revenue
|
84.2
|
|
67.6
|
|
25
|
Operating profit
|
10.8
|
|
9.3
|
|
16
|
Adjusted operating profit*
|
11.8
|
|
9.8
|
|
20
|
* See notes 1 and 2 for definitions
and reconciliations.
The Aerospace & Industrial
division designs and manufactures a wide range of specialist
filtration products, demand for which is driven by customers
seeking better engineered, cleaner, safer or more efficient
operations. Differentiation is achieved through design
engineering; the development of intellectual property; quality
accreditations; and customer service.
Revenue in the year grew by 25%.
Aerospace revenues grew 21% as passenger air miles exceeded
pre-pandemic levels. Petrochemical sales, which can be lumpy,
were up 37% helped by tightening emissions standards, notably in
India, and a gasification order, some of which will ship in 2025.
Growth was further enhanced by EFC, acquired in December
2023, which had a good maiden year with the Group. These were
offset by relative weakness in general US industrial markets,
including microelectronics which remained sluggish for most of the
year. A recovery in these markets, which picked up a little
in the final quarter, is an opportunity for 2025.
Adjusted operating profits rose 20%.
Adjusted operating margins eased to 14.0% (2023: 14.5%) due
to a higher mix of petrochemical revenues and operational gearing
in the US plants. It was a good year for product
introductions with new filters specified on the LEAP aero engine
programme and Blue Origin rockets and new customers for the line of
de-misting filters acquired with EFC.
Laboratory
|
2024
|
|
2023
|
|
Growth
|
|
£m
|
|
£m
|
|
%
|
Revenue
|
64.4
|
|
60.4
|
|
7
|
Operating profit
|
8.7
|
|
8.8
|
|
(1)
|
Adjusted operating profit*
|
9.5
|
|
9.2
|
|
3
|
* See notes 1 and 2 for definitions
and reconciliations.
The Laboratory division has two
operating businesses: Porvair Sciences (including Finneran,
Kbiosystems and Ratiolab) and Seal Analytical.
· Porvair Sciences manufactures laboratory filters, small
instruments and associated consumables, for which demand is driven
by sample preparation in analytical laboratories.
Differentiation is achieved through proprietary manufacturing
capabilities; control of filtration media; and customer
service.
· Seal
Analytical supplies instruments and consumables to environmental
laboratories, for which demand is driven by water quality
regulations. Differentiation is achieved through consistent
new product development focused on improving detection limits, and
improving laboratory automation.
Revenue growth of 7% and adjusted
operating profit growth of 3% included a full year contribution
from Ratiolab, acquired in July 2023. Without this,
underlying revenues fell 1% and operating profits were broadly
flat. After a quieter first half we had expected demand to
pick up and, while order patterns did improve, this did not feed
through into better revenues until late in the year. We took
the opportunity of lower demand to address several longer-term
issues which we expect to benefit from in 2025. Seal
Analytical changed its partner in China; accelerated investments in
Hungary increased capacity and in-house manufacturing capability; a
new sales operation was opened in India; and new product trials on
a range of instruments at both Seal and Kbiosystems were
successful. All bode well for 2025 and beyond.
Metal Melt Quality
|
2024
|
|
2023
|
|
Growth
|
|
£m
|
|
£m
|
|
%
|
Revenue
|
44.1
|
|
48.0
|
|
(8)
|
Operating profit
|
5.9
|
|
6.5
|
|
(9)
|
Adjusted operating profit*
|
5.9
|
|
6.5
|
|
(9)
|
* See notes 1 and 2 for definitions
and reconciliations.
The Metal Melt Quality division
manufactures filters for molten aluminium, ductile iron and
nickel-cobalt alloys. It has a well-differentiated product
range based on patented products and extensive experience in melt
quality assessment.
An 8% fall in revenue in 2024
followed record sales years in 2023 (+6%), 2022 (+21%), and 2021
(+14%). Aluminium revenue was flat in a year where global primary
aluminium production fell around 23% [source: international
aluminium.org]. Demand for aerospace-related turbine blade
filters was robust, generating record revenues for the product
line. Operations in China ran well, generating a modest
profit; but US general industrial demand, notably for the auto,
truck and agricultural markets, was lower. In the final
quarter trading conditions improved, but operations in
Hendersonville North Carolina were badly hit by Hurricane Helene in
late September which caused extensive flooding in the plant.
We are in negotiation with our insurers and FEMA, but
reported operating profits include a charge of £0.9 million for
remediation costs. Operating profit was reduced as a result
with reported margins at 13.4%.
Looking ahead, benefits of US
re-shoring, notably in aluminium recycling, are increasingly
noticeable; and market share wins in turbine blade filtration in
2024 will benefit 2025. The Board has approved capital to
replace one of the key ovens in Hendersonville. This is a
significant investment for the Group. These assets require
replacement on a 20-25 year cycle. The new oven will be
commissioned at the end of 2025 and will increase capacity, lower
unit costs and improve carbon intensity.
Dividends
The Board recommends a final
dividend of 4.2 pence per share, at a value of £1.9 million (2023: 4.0 pence per
share, at a value of £1.8 million). The full year dividend
increases by 5.0%
to 6.3 pence per share, a value of £2.9 million (2023: 6.0 pence per
share, a value of £2.8 million). The Company had
£57.1 million
(2023: £45.5 million) of distributable reserves at 30 November
2024.
Staff
It is when challenged that the
quality of our staff is most evident. A great example in 2024
was in the aftermath of Hurricane Helene, which caused significant
damage in North Carolina. It took a huge team effort in
Hendersonville to maintain production and customer service.
The Board salutes the resourcefulness and perseverance of all
our staff.
The Board maintains direct contact
with all staff members through our Employee Engagement process
which helps general managers in their communication and staff
support activities. All staff comments and suggestions are
read at Board level, and the overwhelming tone of these comments is
constructive. We are very grateful for the hard work,
enthusiasm and dedication of all our staff.
CEO
succession
As announced on 16 April 2024, I
have notified the Board of my decision to retire from the Group.
As further announced on 23 September 2024, Hooman Caman Javvi
has been appointed to the Board as Chief Executive Officer
designate. Hooman joined the Group on 6 January 2025 and will
assume the role of Chief Executive Officer on my retirement,
following the Company's AGM on 15 April 2025.
Current trading and outlook
Porvair delivered record revenue and
profits in 2024, posting percentage revenue growth in line with its
20-year trading record. Trading conditions were mixed, with
strength in aerospace and petrochemical markets offsetting weakness
in laboratory and industrial consumables. The Group's
strategy, unchanged since 2004, continues to deliver consistent
results despite some end-market inconsistency. The Group
focuses on markets with long-term secular growth drivers:
tightening environmental regulation; the growth of analytical
science; the need for clean water; the development of
carbon-efficient transportation; the replacement of plastic and
steel by aluminium; and the drive for manufacturing process quality
and efficiency. These trends underpin our trading record and
enable the Board to make longer-term plans, as set out in our ESG
report published alongside these results. In the nearer term
there is much to look forward to in 2025: new product introductions
in aerospace, Seal Analytical and Kbiosystems; the installation of
a new manufacturing line for aluminium filtration; industrial
demand recovery in the US; and increased Laboratory in-house
manufacturing through Hungary. 2025 will also be a year of
management transition as I will retire as CEO and the new team of
Hooman Caman Javvi and James Mills will take the Group forward and
build on the strength of our model. The Board is optimistic for the
future.
Ben
Stocks
Group Chief Executive
7 February 2025
Financial review
Group results
|
2024
|
|
2023
|
|
Growth
|
|
£m
|
|
£m
|
|
%
|
Revenue
|
192.6
|
|
176.0
|
|
9
|
Operating profit
|
22.8
|
|
21.2
|
|
8
|
Profit before tax
|
20.9
|
|
20.1
|
|
4
|
Profit after tax
|
16.6
|
|
16.0
|
|
4
|
Revenue was 9% higher on a reported
currency basis and 13% higher at constant currency (see note 1).
Operating profit was £22.8 million (2023: £21.2 million) and profit
before tax was £20.9 million (2023: £20.1 million). Profit after
tax was £16.6 million (2023: £16.0 million). An operating
review, together with a review of divisional performance, is
included in the Chief Executive's report above.
Alternative performance measures - profit
|
2024
|
|
2023
|
|
Growth
|
|
£m
|
|
£m
|
|
%
|
Adjusted operating profit
|
24.5
|
|
22.6
|
|
8
|
Adjusted profit before tax
|
22.7
|
|
21.4
|
|
6
|
Adjusted profit after tax
|
17.9
|
|
17.1
|
|
5
|
The Group presents alternative
performance measures to enable a better understanding of its
trading performance (see note 1). Adjusted operating profit
and adjusted profit before tax exclude items that are material and
where treatment as an adjusting item provides a more consistent
assessment of the Group's trading performance. Adjusting
items comprise £1.7 million (2023: £0.9 million) for the
amortisation of acquired intangible assets and £nil (2023: £0.4
million) for costs incurred in relation to the acquisition of
certain business and assets from HRW Inc., which completed in March
2023; the 100% share capital of Ratiolab, which completed in July
2023; and the 100% share capital of EFC, which completed in
December 2023.
Impact of exchange rate movements on
performance
The international nature of the
Group's business means that relative movements in exchange rates
can affect reported performance. The rates used for
translating the results of overseas operations were:
|
2024
|
|
2023
|
Average rate for translating the
results:
|
|
|
|
US$ denominated
operations
|
$1.28:£1
|
|
$1.24:£1
|
Euro denominated
operations
|
€1.18:£1
|
|
€1.15:£1
|
Closing rate for translating the
balance sheet:
|
|
|
|
US$ denominated
operations
|
$1.27:£1
|
|
$1.27:£1
|
Euro denominated
operations
|
€1.20:£1
|
|
€1.16:£1
|
During the year, the Group sold
US$29.8 million (2023: US$28.5 million) at a net rate of US$1.26:£1
(2023: US$1.21:£1) and purchased €3.8 million (2023: net €4.6
million) at a net rate of €1.20:£1 (2023: €1.15:£1). At 30 November
2024, the Group had US$4.0 million (2023: US$10.0 million) of
outstanding forward foreign exchange contracts; hedge accounting
has not been applied to these contracts.
Finance costs
Net finance costs comprise interest
on borrowings; lease liabilities; and the Group's retirement
benefit obligations; together with the cost of unwinding discounts
on provisions and other payables. The Group also incurs
undrawn commitment fees on the Group's available banking
facilities. Net finance costs of £1.9 million (2023: £1.2
million) increased in the year primarily due to interest on
borrowings; lease liability interest associated with a property
lease renewal in the UK; and lease liability interest on properties
which came with the Ratiolab and EFC acquisitions. Interest
cover from operating profit was 12 times (2023: 18 times).
Interest cover from operating profit on net bank finance costs only
was 33 times (2023: 65 times).
Tax
The total Group tax charge for the
year was £4.3 million (2023: £4.1 million), including the tax
effect of the adjusting items set out in note 1. The adjusted
tax charge was £4.8 million (2023: £4.3 million), with the
effective rate of income tax on adjusted profit before tax at 21%
(2023: 20%).
The Group has current tax provisions
of £1.6 million (2023: £0.6 million), which includes £0.9 million
(2023: £1.1 million) for uncertainties relating to the
interpretation of tax legislation in the Group's operating
territories, offset by payments on account and amounts recoverable
for overpayments of tax.
The Group carries a deferred tax
asset of £0.1 million (2023: £0.4 million) and a deferred tax
liability of £3.7 million (2023: £3.6 million). The deferred tax
asset relates principally to retirement benefit obligations and
share-based payments. The deferred tax liability relates to
accelerated capital allowances, acquired intangible assets arising
on consolidation and other timing differences.
Total equity and distributable reserves
Total equity at 30 November 2024 was
£153.3 million (2023: £140.4 million), an increase of 9% over the
prior year. The net increase in total equity includes profit
after tax of £16.6 million (2023: £16.0 million), a net of tax
actuarial loss of £0.1 million (2023: gain £0.2 million), together
with a £1.6 million exchange loss (2023: £4.6 million) on the
retranslation of foreign subsidiaries.
The Company had £57.1 million (2023:
£45.5 million) of distributable reserves at 30 November 2024.
The Company's distributable reserves increased in the year from
dividends received from Group companies, and decreased in the year
from head office costs and dividends paid to
shareholders.
Cash flow, cash and net debt
The table below summarises the key
elements of the cash flow for the year:
|
2024
|
|
2023
|
|
£m
|
|
£m
|
Operating cash flow before working
capital
|
31.7
|
|
29.1
|
Working capital movement
|
(3.8)
|
|
(2.8)
|
Post-employment benefits
|
(2.2)
|
|
(2.2)
|
Cash generated from
operations
|
25.7
|
|
24.1
|
Interest
|
(0.7)
|
|
(0.3)
|
Tax
|
(3.4)
|
|
(3.0)
|
Capital expenditure
|
(5.1)
|
|
(4.8)
|
|
16.5
|
|
16.0
|
Acquisitions (net of cash
acquired)
|
(10.2)
|
|
(13.9)
|
Share issue proceeds
|
0.6
|
|
0.1
|
Purchase of Employee Benefit Trust
shares
|
(0.7)
|
|
(0.7)
|
Increase in borrowings
|
10.7
|
|
9.8
|
Decrease in borrowings
|
(10.7)
|
|
(9.8)
|
Dividends
|
(2.8)
|
|
(2.7)
|
Repayment of lease
liabilities
|
(3.5)
|
|
(2.6)
|
Decrease in cash
|
(0.1)
|
|
(3.8)
|
|
|
|
|
Net
(debt)/cash reconciliation
|
2024
|
|
2023
|
|
£m
|
|
£m
|
Net cash at 1 December
|
0.7
|
|
6.8
|
Decrease in cash
|
(0.1)
|
|
(3.8)
|
Net movement in borrowings
|
-
|
|
-
|
Increase in lease
liabilities
|
(4.4)
|
|
(2.1)
|
Exchange
|
0.1
|
|
(0.2)
|
Net
(debt)/cash at 30 November
|
(3.7)
|
|
0.7
|
Cash and cash equivalents
|
13.7
|
|
14.1
|
Lease liabilities
|
(17.4)
|
|
(13.4)
|
Net
(debt)/cash at 30 November
|
(3.7)
|
|
0.7
|
Generating free cash flow is central
to the Group's business model. Cash generated from operations
was £25.7 million (2023: £24.1 million), with net working capital
increasing by £3.8 million (2023: £2.8 million). The Group
started the year with cash and cash equivalents of £14.1 million
and finished the year with £13.7 million, having invested £15.3
million in capital expenditure and acquisitions (2023: £18.7
million).
In August 2024, the Group agreed
with Barclays Bank plc and Citibank N.A., London Branch, a new €20
million four year secured revolving credit facility with the option
to extend by one year, plus a €20 million accordion. The
agreement was a refinance of the Group's existing €28 million
facilities and €17 million accordion. A margin benefit
remains for delivering progress against certain sustainability
targets. The Group continues to have a £2.5 million overdraft
facility provided by Barclays Bank plc.
Bank borrowings at 30 November 2024
were £nil (2023: £nil). As at 30 November 2024, the Group had
€19.6 million/£16.3 million (2023: €27.8 million/£24.0 million) of
unused credit facilities and an unutilised £2.5 million (2023: £2.5
million) net overdraft facility.
Capital expenditure
Capital expenditure on property,
plant and equipment was £5.1 million (2023: £4.8 million), as the
Group continued to invest in capital projects with a particular
emphasis on automation, productivity and capacity. During the
year, the Board approved a £5.5 million capital investment
programme for the update and expansion of the Group's aluminium
cast house production capabilities in Hendersonville. The
project began in the second half of the year.
Acquisitions
On 4 December 2023, the Group
acquired 100% of the share capital of European Filter Corporation
NV ("EFC"), on a cash free, debt free basis and subject to an
agreed level of working capital. Consideration paid was £10.3
million. Further details of the acquisition are disclosed in
note 9.
Provisions
The Group has £3.6 million (2023:
£3.6 million) of provisions for dilapidations and performance
warranties. £0.7 million of provisions have been created for sales
made in the year, whilst £0.2 million of provisions have been
released following the latest estimate of the expected costs to be
incurred and £0.5 million of provisions have been
utilised.
Retirement benefit obligations
Retirement benefit obligations
measured in accordance with IAS 19 Employee Benefits were £5.9 million
(2023: £7.7 million). The Group supports its defined benefit
pension scheme in the UK ("the Plan"), which is closed to new
entrants, and provides access to defined contribution schemes for
its other employees. The Plan's liabilities increased in the
year to £31.3 million (2023: £30.8 million). The Plan's
assets also increased in the year to £25.5 million (2023: £23.3
million). Following a change in financial and demographic
assumptions, a net of tax actuarial loss of £0.1 million (2023:
gain £0.2 million) was recognised within the statement of
comprehensive income. Cash contributions paid to the Plan
were £2.6 million (2023: £2.6 million), which included a deficit
recovery payment of £2.1 million (2023: £2.1 million). The 31
March 2024 triennial valuation of the Plan is in progress and is
expected to be finalised before 30 June 2025.
Finance and treasury policy
The treasury function at Porvair is
managed centrally, under Board supervision. It seeks to limit
the Group's trading exposure to currency movements. The Group
does not hedge against the impact of exchange rate movements on the
translation of profits and losses of overseas operations. The
Group finances its operations through share capital, retained
profits and, when required, bank debt. It has adequate
facilities to finance its current operations and capital plans for
the foreseeable future.
James Mills
Group Finance Director
7 February 2025
Consolidated income statement
For
the year ended 30 November
|
|
|
2024
|
|
2023
|
Continuing operations
|
|
Note
|
£'000
|
|
£'000
|
Revenue
|
|
1,2
|
192,639
|
|
176,013
|
Cost of sales
|
|
|
(127,534)
|
|
(113,719)
|
Gross profit
|
|
|
65,105
|
|
62,294
|
Distribution costs
|
|
|
(3,524)
|
|
(2,569)
|
Administrative expenses
|
|
|
(38,784)
|
|
(38,485)
|
Adjusted operating profit
|
|
1,2
|
24,540
|
|
22,571
|
Adjustments:
|
|
|
|
|
|
Amortisation of acquired intangible assets
|
|
|
(1,743)
|
|
(872)
|
Other acquisition-related costs
|
|
|
-
|
|
(459)
|
Operating profit
|
|
1,2
|
22,797
|
|
21,240
|
Finance income
|
|
|
51
|
|
126
|
Finance costs
|
|
|
(1,936)
|
|
(1,276)
|
Profit before tax
|
|
|
20,912
|
|
20,090
|
Adjusted income tax expense
|
|
|
(4,751)
|
|
(4,324)
|
Adjustments:
|
|
|
|
|
|
Tax effect of adjustments to operating
profit
|
|
1
|
441
|
|
204
|
Income tax expense
|
|
|
(4,310)
|
|
(4,120)
|
Profit for the year
|
|
|
16,602
|
|
15,970
|
Profit attributable to:
|
|
|
|
|
|
- Owners of
the parent
|
|
|
16,479
|
|
15,970
|
-
Non-controlling interests
|
|
|
123
|
|
-
|
Profit for the year
|
|
|
16,602
|
|
15,970
|
|
|
|
|
|
|
Earnings per share (basic)
|
|
3
|
35.8p
|
|
34.8p
|
Earnings per share (diluted)
|
|
3
|
35.8p
|
|
34.8p
|
|
|
|
|
|
|
Adjusted earnings per share (basic)
|
|
3
|
38.6p
|
|
37.2p
|
Adjusted earnings per share (diluted)
|
|
3
|
38.6p
|
|
37.2p
|
Consolidated statement of comprehensive
income
For
the year ended 30 November
|
|
2024
£'000
|
|
2023
£'000
|
Profit for the year
|
|
16,602
|
|
15,970
|
Other comprehensive (loss)/income
|
|
|
|
|
Items that will not be reclassified to profit and
loss:
|
|
|
|
|
Actuarial (loss)/gain in defined
benefit pension plans net of tax
|
|
(64)
|
|
227
|
Items that may be subsequently reclassified to profit and
loss:
|
|
|
|
Exchange loss on translation of
foreign subsidiaries
|
|
(1,566)
|
|
(4,628)
|
Total other comprehensive loss for the year
|
|
(1,630)
|
|
(4,401)
|
Total comprehensive income for the year
|
|
14,972
|
|
11,569
|
Comprehensive income attributable to:
|
|
|
|
|
- Owners of
the parent
|
|
14,849
|
|
11,569
|
-
Non-controlling interests
|
|
123
|
|
-
|
Total comprehensive income for the year
|
|
14,972
|
|
11,569
|
|
|
|
|
|
|
|
|
|
|
Consolidated balance sheet
As
at 30 November
|
Note
|
|
2024
£'000
|
|
2023
£'000
|
Non-current assets
|
|
|
|
|
|
Property, plant and
equipment
|
|
|
29,327
|
|
28,329
|
Right-of-use assets
|
|
|
16,433
|
|
12,136
|
Goodwill and other intangible
assets
|
|
|
89,792
|
|
82,949
|
Deferred tax asset
|
|
|
84
|
|
401
|
|
|
|
135,636
|
|
123,815
|
Current assets
|
|
|
|
|
|
Inventories
|
|
|
31,969
|
|
31,898
|
Trade and other
receivables
|
|
|
31,665
|
|
23,268
|
Derivative financial
instruments
|
|
|
7
|
|
250
|
Cash
|
|
|
15,838
|
|
16,839
|
|
|
|
79,479
|
|
72,255
|
Current liabilities
|
|
|
|
|
|
Trade and other payables
|
|
|
(27,408)
|
|
(23,827)
|
Bank overdrafts
|
|
|
(2,097)
|
|
(2,787)
|
Current tax liabilities
|
|
|
(1,572)
|
|
(594)
|
Lease liabilities
|
|
|
(2,487)
|
|
(2,057)
|
Derivative financial
instruments
|
|
|
(40)
|
|
-
|
Provisions
|
5
|
|
(3,256)
|
|
(3,243)
|
|
|
|
(36,860)
|
|
(32,508)
|
Net
current assets
|
|
|
42,619
|
|
39,747
|
|
|
|
|
|
|
Non-current liabilities
|
|
|
|
|
|
Deferred tax liability
|
|
|
(3,704)
|
|
(3,583)
|
Retirement benefit
obligations
|
|
|
(5,897)
|
|
(7,713)
|
Other payables
|
|
|
(85)
|
|
(123)
|
Lease liabilities
|
|
|
(14,969)
|
|
(11,342)
|
Provisions
|
5
|
|
(346)
|
|
(363)
|
|
|
|
(25,001)
|
|
(23,124)
|
Net
assets
|
|
|
153,254
|
|
140,438
|
|
|
|
|
|
|
Capital and reserves
|
|
|
|
|
|
Share capital
|
|
|
930
|
|
927
|
Share premium account
|
|
|
38,407
|
|
37,778
|
Cumulative translation
reserve
|
|
|
9,259
|
|
10,825
|
Retained earnings
|
|
|
104,530
|
|
90,908
|
Equity attributable to owners of the parent
|
|
|
153,126
|
|
140,438
|
Non-controlling interests
|
|
|
128
|
|
-
|
Total equity
|
|
|
153,254
|
|
140,438
|
Consolidated cash flow statement
For
the year ended 30 November
|
Note
|
|
2024
£'000
|
|
2023
£'000
|
Cash
flows from operating activities
|
|
|
|
|
|
Cash generated from
operations
|
8
|
|
25,744
|
|
24,079
|
Interest paid
|
|
|
(739)
|
|
(452)
|
Tax paid
|
|
|
(3,488)
|
|
(3,027)
|
Net
cash generated from operating activities
|
|
|
21,517
|
|
20,600
|
|
|
|
|
|
|
Cash
flows from investing activities
|
|
|
|
|
|
Interest received
|
|
|
49
|
|
122
|
Acquisition of subsidiaries (net of
cash acquired)
|
9
|
|
(10,204)
|
|
(9,957)
|
Settlement of debt acquired on
acquisition
|
|
|
-
|
|
(3,955)
|
Purchase of property, plant and
equipment
|
|
|
(4,839)
|
|
(4,702)
|
Purchase of intangible
assets
|
|
|
(289)
|
|
(107)
|
Proceeds from sale of property, plant
and equipment
|
|
|
5
|
|
-
|
Proceeds from sale of share capital
of non-controlling interests
|
|
5
|
|
-
|
Net
cash used in investing activities
|
|
|
(15,273)
|
|
(18,599)
|
|
|
|
|
|
|
Cash
flows from financing activities
|
|
|
|
|
|
Proceeds from issue of ordinary
shares
|
|
|
632
|
|
152
|
Purchase of Employee Benefit Trust
shares
|
|
|
(724)
|
|
(745)
|
Proceeds of loans and
borrowings
|
|
|
10,721
|
|
9,818
|
Repayments of loans and
borrowings
|
|
|
(10,721)
|
|
(9,818)
|
Dividends paid to
shareholders
|
4
|
|
(2,811)
|
|
(2,664)
|
Repayments of lease
liabilities
|
|
|
(3,485)
|
|
(2,551)
|
Net
cash used in financing activities
|
|
|
(6,388)
|
|
(5,808)
|
|
|
|
|
|
|
Net
decrease in cash and cash equivalents
|
|
|
(144)
|
|
(3,807)
|
Effects of exchange rate
changes
|
|
(167)
|
|
(438)
|
|
|
|
(311)
|
|
(4,245)
|
Cash and cash equivalents at 1
December
|
|
|
14,052
|
|
18,297
|
Cash
and cash equivalents at 30 November
|
|
|
13,741
|
|
14,052
|
Reconciliation of net cash flow to movement
in net (debt)/cash
|
|
2024
£'000
|
|
2023
£'000
|
|
|
|
|
|
Net cash at 1 December
|
|
653
|
|
6,825
|
Decrease in
cash and cash equivalents
|
|
(144)
|
|
(3,807)
|
Net movement in
borrowings
|
|
-
|
|
-
|
Net debt acquired in the
year
|
|
-
|
|
(3,955)
|
Settlement of debt acquired on
acquisition
|
|
-
|
|
3,955
|
Lease liabilities additions, exits
and accretion of interest
|
|
(4,994)
|
|
(2,493)
|
Lease liabilities
acquired
|
|
(2,044)
|
|
(1,858)
|
Lease liabilities interest
incurred
|
|
(811)
|
|
(368)
|
Lease liabilities repaid
|
|
3,485
|
|
2,551
|
Effects of exchange rate
changes
|
|
140
|
|
(197)
|
Net
debt/(cash) at 30 November
|
|
(3,715)
|
|
653
|
Cash and cash equivalents
|
|
13,741
|
|
14,052
|
Lease liabilities
|
|
(17,456)
|
|
(13,399)
|
Net
(debt)/cash at 30 November
|
|
(3,715)
|
|
653
|
Consolidated statement of changes in equity
For
the year ended 30 November
|
Share
capital
£'000
|
Share
premium
account
£'000
|
Cumulative
translation
reserve
£'000
|
Retained
earnings
£'000
|
Non-controlling
interest
£'000
|
Total
equity
£'000
|
At 1 December 2022
|
927
|
37,626
|
15,453
|
77,062
|
-
|
131,068
|
Profit for the year
|
-
|
-
|
-
|
15,970
|
-
|
15,970
|
Other comprehensive loss
|
-
|
-
|
(4,628)
|
227
|
-
|
(4,401)
|
Total comprehensive income for the
year
|
-
|
-
|
(4,628)
|
16,197
|
-
|
11,569
|
Purchase of own shares (held in
trust)
|
-
|
-
|
-
|
(745)
|
-
|
(745)
|
Issue of ordinary share
capital
|
-
|
152
|
-
|
-
|
-
|
152
|
Share-based payments (net of
tax)
|
-
|
-
|
-
|
1,058
|
-
|
1,058
|
Dividends paid
|
-
|
-
|
-
|
(2,664)
|
-
|
(2,664)
|
At 30 November 2023
|
927
|
37,778
|
10,825
|
90,908
|
-
|
140,438
|
|
|
|
|
|
|
|
Profit for the year
|
-
|
-
|
-
|
16,479
|
123
|
16,602
|
Other comprehensive loss
|
-
|
-
|
(1,566)
|
(64)
|
-
|
(1,630)
|
Total comprehensive income for the
year
|
-
|
-
|
(1,566)
|
16,415
|
123
|
14,972
|
Purchase of own shares (held in
trust)
|
-
|
-
|
-
|
(724)
|
-
|
(724)
|
Issue of ordinary share
capital
|
3
|
629
|
-
|
-
|
-
|
632
|
Share-based payments (net of
tax)
|
-
|
-
|
-
|
742
|
-
|
742
|
Changes in non-controlling
interests
|
-
|
-
|
-
|
-
|
5
|
5
|
Dividends paid
|
-
|
-
|
-
|
(2,811)
|
-
|
(2,811)
|
At
30 November 2024
|
930
|
38,407
|
9,259
|
104,530
|
128
|
153,254
|
Notes
1. Alternative
performance measures
Alternative performance measures are
used by the Directors and management to monitor business
performance internally and exclude certain cash and non-cash items
which they believe are not reflective of the normal course of
business of the Group. The Directors believe that disclosing
such non-IFRS measures enables a reader to isolate and evaluate the
impact of such items on results and allows for a fuller
understanding of performance from year to year. Alternative
performance measures may not be directly comparable with other
similarly titled measures used by other companies.
Alternative revenue measures
|
|
2024
|
|
2023
|
|
Growth
|
Aerospace & Industrial
|
|
£'000
|
|
£'000
|
|
%
|
Underlying revenue
|
|
72,925
|
|
64,418
|
|
13
|
Acquisition
|
|
9,290
|
|
-
|
|
|
Revenue at constant
currency
|
|
82,215
|
|
64,418
|
|
28
|
Exchange
|
|
2,002
|
|
3,218
|
|
|
Revenue as reported
|
|
84,217
|
|
67,636
|
|
25
|
|
|
|
|
|
|
|
Laboratory
|
|
|
|
|
|
|
Underlying revenue
|
|
53,251
|
|
53,574
|
|
(1)
|
Acquisition
|
|
8,193
|
|
2,799
|
|
|
Revenue at constant
currency
|
|
61,444
|
|
56,373
|
|
9
|
Exchange
|
|
2,919
|
|
4,013
|
|
|
Revenue as reported
|
|
64,363
|
|
60,386
|
|
7
|
|
|
|
|
|
|
|
Metal Melt Quality
|
|
|
|
|
|
|
Revenue at constant
currency
|
|
40,291
|
|
42,329
|
|
(5)
|
Exchange
|
|
3,768
|
|
5,662
|
|
|
Revenue as reported
|
|
44,059
|
|
47,991
|
|
(8)
|
|
|
|
|
|
|
|
Group
|
|
|
|
|
|
|
Underlying revenue
|
|
166,467
|
|
160,321
|
|
4
|
Acquisitions
|
|
17,483
|
|
2,799
|
|
|
Revenue at constant
currency
|
|
183,950
|
|
163,120
|
|
13
|
Exchange
|
|
8,689
|
|
12,893
|
|
|
Revenue as reported
|
|
192,639
|
|
176,013
|
|
9
|
Revenue at constant currency is
derived from translating overseas subsidiaries results at budgeted
fixed exchange rates. In 2024 and 2023, the rates used were
US$1.40:£1 and €1.20:£1, compared with reported rates of US$1.28:£1
(2023: US$1.24:£1) and €1.18:£1 (2023: €1.15:£1).
Underlying revenue is revenue at
constant currency adjusted for the impact of acquisitions made in
the current and prior year.
The acquisition lines relate
separately to revenue from EFC and Ratiolab, acquired in December
2023 and July 2023 respectively. HRW, acquired in March 2023,
expanded the Group's previously outsourced machining capability and
has no external revenue.
Alternative profit measures
A reconciliation of the Group's
adjusted performance measures to the reported IFRS measures is
presented below:
|
|
|
2024
|
|
|
|
2023
|
|
|
|
Adjusted
|
Adjustments
|
Reported
|
|
Adjusted
|
Adjustments
|
Reported
|
|
|
£'000
|
£'000
|
£'000
|
|
£'000
|
£'000
|
£'000
|
Operating profit
|
24,540
|
(1,743)
|
22,797
|
|
22,571
|
(1,331)
|
21,240
|
Finance income
|
51
|
-
|
51
|
|
126
|
-
|
126
|
Finance costs
|
(1,936)
|
-
|
(1,936)
|
|
(1,276)
|
-
|
(1,276)
|
Profit before tax
|
22,655
|
(1,743)
|
20,912
|
|
21,421
|
(1,331)
|
20,090
|
Income tax expense
|
(4,751)
|
441
|
(4,310)
|
|
(4,324)
|
204
|
(4,120)
|
Profit for the year
|
17,904
|
(1,302)
|
16,602
|
|
17,097
|
(1,127)
|
15,970
|
|
|
|
|
|
|
|
| |
An analysis of adjusting items is
given below:
|
2024
|
|
2023
|
Affecting operating profit:
|
£'000
|
|
£'000
|
Amortisation of acquired intangible assets
|
(1,743)
|
|
(872)
|
Other acquisition-related costs
|
-
|
|
(459)
|
|
(1,743)
|
|
(1,331)
|
Affecting tax:
|
|
|
|
Tax effect of adjustments to operating
profit
|
441
|
|
204
|
Total adjusting items
|
(1,302)
|
|
(1,127)
|
Adjusted operating profit
excludes:
· the amortisation of intangible assets
arising on acquisition of businesses of £1.7 million (2023: £0.9 million);
and
· other
acquisition-related costs of £nil (2023: £0.4 million) incurred in
relation to the acquisition of certain business and assets from HRW
in March 2023; the 100% share capital of Ratiolab acquired in July
2023; and the 100% share capital of EFC acquired in December 2023
(note 9).
Return on capital employed
The Group uses two return measures
to assess the return it makes on its investments:
· adjusted post tax return on capital employed of
15% (2023: 15%) is the tax
adjusted operating profit as a percentage of the average capital
employed. Capital employed is the average of the opening and
closing Group net assets less the average of the opening and
closing cash and cash equivalents, and borrowings; and
· adjusted post tax return on operating capital employed
of 32% (2023: 34%)
is calculated on the same basis except that the capital employed is
adjusted to remove the average of the opening and closing goodwill
and the opening and closing net of tax retirement benefit
obligations to give a measure of the operating
capital.
2. Segment
information
The chief operating decision maker
has been identified as the Board of Directors. The Board of
Directors has instructed the Group's internal reporting to be based
around differences in products and services, in order to assess
performance and allocate resources. The key profit measure
used to assess the performance of each reportable segment is
adjusted operating profit/(loss). Management has determined
the operating segments based on this reporting.
As at 30 November 2024, the Group is
organised on a worldwide basis into three operating
segments:
1) Aerospace &
Industrial - principally serving the aviation, and energy and
industrial markets;
2) Laboratory -
principally serving the bioscience and environmental laboratory
instrument and consumables market; and
3) Metal Melt Quality -
principally serving the global aluminium, North American Free Trade
Agreement ("NAFTA") iron foundry and superalloys
markets.
Other Group operations' costs,
assets and liabilities are included in the "Central" division.
Central costs mainly comprise Group corporate costs,
including new business development costs, some research and
development costs and general financial costs. Central assets
and liabilities mainly comprise Group retirement benefit
obligations, tax assets and liabilities, cash and
borrowings.
The segment results for the year
ended 30 November 2024 are as follows:
|
Aerospace &
Industrial
|
|
Laboratory
|
|
Metal Melt
Quality
|
|
Central
|
|
Group
|
|
£'000
|
|
£'000
|
|
£'000
|
|
£'000
|
|
£'000
|
Total segment revenue
|
84,266
|
|
65,840
|
|
44,059
|
|
-
|
|
194,165
|
Inter-segment revenue
|
(49)
|
|
(1,477)
|
|
-
|
|
-
|
|
(1,526)
|
Revenue
|
84,217
|
|
64,363
|
|
44,059
|
|
-
|
|
192,639
|
|
|
|
|
|
|
|
|
|
|
Adjusted operating
profit/(loss)
|
11,804
|
|
9,503
|
|
5,917
|
|
(2,684)
|
|
24,540
|
Amortisation of acquired intangible assets
|
(958)
|
|
(785)
|
|
-
|
|
-
|
|
(1,743)
|
Operating profit/(loss)
|
10,846
|
|
8,718
|
|
5,917
|
|
(2,684)
|
|
22,797
|
Finance income
|
-
|
|
-
|
|
-
|
|
51
|
|
51
|
Finance costs
|
-
|
|
-
|
|
-
|
|
(1,936)
|
|
(1,936)
|
Profit/(loss) before tax
|
10,846
|
|
8,718
|
|
5,917
|
|
(4,569)
|
|
20,912
|
The segment results for the year
ended 30 November 2023 are as follows:
|
Aerospace
&
Industrial
|
|
Laboratory
|
|
Metal Melt
Quality
|
|
Central
|
|
Group
|
|
£'000
|
|
£'000
|
|
£'000
|
|
£'000
|
|
£'000
|
Total segment revenue
|
67,661
|
|
62,106
|
|
47,991
|
|
-
|
|
177,758
|
Inter-segment revenue
|
(25)
|
|
(1,720)
|
|
-
|
|
-
|
|
(1,745)
|
Revenue
|
67,636
|
|
60,386
|
|
47,991
|
|
-
|
|
176,013
|
|
|
|
|
|
|
|
|
|
|
Adjusted operating profit/(loss)
|
9,780
|
|
9,215
|
|
6,547
|
|
(2,971)
|
|
22,571
|
Amortisation of acquired intangible assets
|
(446)
|
|
(426)
|
|
-
|
|
-
|
|
(872)
|
Other acquisition-related costs
|
(23)
|
|
-
|
|
-
|
|
(436)
|
|
(459)
|
Operating profit/(loss)
|
9,311
|
|
8,789
|
|
6,547
|
|
(3,407)
|
|
21,240
|
Finance income
|
-
|
|
-
|
|
-
|
|
126
|
|
126
|
Finance costs
|
-
|
|
-
|
|
-
|
|
(1,276)
|
|
(1,276)
|
Profit/(loss) before tax
|
9,311
|
|
8,789
|
|
6,547
|
|
(4,557)
|
|
20,090
|
The segment assets and liabilities at
30 November 2024 are as follows:
|
Aerospace &
Industrial
|
|
Laboratory
|
|
Metal Melt
Quality
|
|
Central
|
|
Group
|
|
£'000
|
|
£'000
|
|
£'000
|
|
£'000
|
|
£'000
|
Segmental assets
|
87,154
|
|
73,447
|
|
36,477
|
|
2,199
|
|
199,277
|
Cash
|
-
|
|
-
|
|
-
|
|
15,838
|
|
15,838
|
Total assets
|
87,154
|
|
73,447
|
|
36,477
|
|
18,037
|
|
215,115
|
|
|
|
|
|
|
|
|
|
|
Segmental liabilities
|
(26,604)
|
|
(12,585)
|
|
(6,573)
|
|
(8,105)
|
|
(53,867)
|
Retirement benefit
obligations
|
-
|
|
-
|
|
-
|
|
(5,897)
|
|
(5,897)
|
Bank overdrafts
|
-
|
|
-
|
|
-
|
|
(2,097)
|
|
(2,097)
|
Total liabilities
|
(26,604)
|
|
(12,585)
|
|
(6,573)
|
|
(16,099)
|
|
(61,861)
|
The segment assets and liabilities
at 30 November 2023 are as follows:
|
Aerospace
&
Industrial
|
|
Laboratory
|
|
Metal Melt
Quality
|
|
Central
|
|
Group
|
|
£'000
|
|
£'000
|
|
£'000
|
|
£'000
|
|
£'000
|
Segmental assets
|
67,456
|
|
74,835
|
|
34,470
|
|
2,470
|
|
179,231
|
Cash
|
-
|
|
-
|
|
-
|
|
16,839
|
|
16,839
|
Total assets
|
67,456
|
|
74,835
|
|
34,470
|
|
19,309
|
|
196,070
|
|
|
|
|
|
|
|
|
|
|
Segmental liabilities
|
(18,709)
|
|
(13,533)
|
|
(6,301)
|
|
(6,589)
|
|
(45,132)
|
Retirement benefit
obligations
|
-
|
|
-
|
|
-
|
|
(7,713)
|
|
(7,713)
|
Bank overdrafts
|
-
|
|
-
|
|
-
|
|
(2,787)
|
|
(2,787)
|
Total liabilities
|
(18,709)
|
|
(13,533)
|
|
(6,301)
|
|
(17,089)
|
|
(55,632)
|
Geographical analysis
|
2024
|
|
2023
|
|
Revenue
|
By
destination
£'000
|
|
By origin
£'000
|
|
By
destination
£'000
|
|
By
origin
£'000
|
United Kingdom
|
20,180
|
|
51,714
|
|
18,588
|
|
48,291
|
Continental Europe
|
54,025
|
|
48,652
|
|
36,707
|
|
28,863
|
United States of America
|
77,731
|
|
87,008
|
|
80,479
|
|
93,609
|
Other NAFTA
|
4,926
|
|
-
|
|
4,298
|
|
-
|
South America
|
1,826
|
|
-
|
|
2,567
|
|
-
|
Asia
|
31,359
|
|
5,265
|
|
31,925
|
|
5,250
|
Africa
|
2,592
|
|
-
|
|
1,449
|
|
-
|
|
192,639
|
|
192,639
|
|
176,013
|
|
176,013
|
|
|
|
|
|
|
|
| |
3. Earnings
per share (EPS)
|
2024
|
|
2023
|
As
reported
|
Earnings
£'000
|
Weighted average number of
shares
|
Per share
Pence
|
|
Earnings
£'000
|
Weighted
average number of shares
|
Per
share
Pence
|
Profit for the year - attributable
to owners of the parent
|
16,479
|
|
|
|
15,970
|
|
|
Shares in issue
|
|
46,399,931
|
|
|
|
46,351,723
|
|
Shares owned by the Employee Benefit
Trust
|
|
(355,411)
|
|
|
|
(439,447)
|
|
Basic EPS
|
16,479
|
46,044,520
|
35.8
|
|
15,970
|
45,912,276
|
34.8
|
Dilutive share options
outstanding
|
-
|
5,762
|
-
|
|
-
|
26,112
|
-
|
Diluted EPS
|
16,479
|
46,050,282
|
35.8
|
|
15,970
|
45,938,388
|
34.8
|
In addition to the above, the Group
also calculates an EPS based on adjusted profit as the Board
believes this to be a better measure to judge the progress of the
Group, as discussed in note 1.
|
2024
|
|
2023
|
Adjusted
|
Earnings
£'000
|
Weighted average number of
shares
|
Per share
Pence
|
|
Earnings
£'000
|
Weighted
average number of shares
|
Per
share
Pence
|
Profit for the year - attributable
to owners of the parent
|
16,479
|
|
|
|
15,970
|
|
|
|
Adjusting items (note 1)
|
1,302
|
|
|
|
1,127
|
|
|
|
Adjusted profit -attributable to
owners of the parent
|
17,781
|
|
|
|
17,097
|
|
|
Adjusted Basic EPS
|
17,781
|
46,044,520
|
38.6
|
|
17,097
|
45,912,276
|
37.2
|
Adjusted Diluted EPS
|
17,781
|
46,050,282
|
38.6
|
|
17,097
|
45,938,388
|
37.2
|
|
|
|
|
|
|
|
|
| |
4.
Dividends per
share
|
2024
|
|
2023
|
|
Per share
|
|
|
Per
share
|
|
|
Pence
|
£'000
|
|
Pence
|
£'000
|
|
|
|
|
|
|
Final dividend paid - in respect of
prior year
|
4.0
|
1,842
|
|
3.8
|
1,745
|
Interim dividend paid - in respect of
current year
|
2.1
|
969
|
|
2.0
|
919
|
|
6.1
|
2,811
|
|
5.8
|
2,664
|
The Directors recommend the payment
of a final dividend of 4.2 pence per share (2023: 4.0 pence per
share) to be paid on 4 June 2025 to shareholders on the register on
2 May 2025; the ex-dividend date is 1 May 2025. This makes a
total dividend for the year of 6.3 pence per share (2023: 6.0 pence
per share).
5.
Provisions
|
|
|
|
Dilapidations
|
|
Warranty
|
|
Total
|
|
|
|
|
£'000
|
|
£'000
|
|
£'000
|
At 1 December 2023
|
|
|
|
363
|
|
3,243
|
|
3,606
|
Additional charge in the
year
|
|
|
|
-
|
|
742
|
|
742
|
Utilisation of provision
|
|
|
|
-
|
|
(509)
|
|
(509)
|
Release of provision
|
|
|
|
(61)
|
|
(199)
|
|
(260)
|
Unwinding of discount
|
|
|
|
44
|
|
-
|
|
44
|
Exchange
|
|
|
|
-
|
|
(21)
|
|
(21)
|
At
30 November 2024
|
|
|
|
346
|
|
3,256
|
|
3,602
|
Provisions arise from potential
claims on major contracts, sale warranties, and discounted
dilapidations for leased property. Matters that could affect
the timing, quantum and extent to which provisions are utilised or
released, include the impact of any remedial work, claims against
outstanding performance bonds, and the demonstrated life of the
filtration equipment installed. The outflow of economic
benefits in relation to warranty provisions is expected to be
within one year, whilst the outflow on dilapidations is expected to
be greater than one year.
|
2024
|
|
2023
|
Analysis of total provisions
|
£'000
|
|
£'000
|
Current
|
3,256
|
|
3,243
|
Non-current
|
346
|
|
363
|
Net
book value at 30 November
|
3,602
|
|
3,606
|
|
|
|
|
| |
6. Contingent
liabilities
At 30 November 2024, the Group had
the following advanced payment and performance bonds issued to
customers in the ordinary course of business:
|
|
|
US$'000
|
|
€'000
|
Advanced payment bonds
|
|
|
-
|
|
4,603
|
Performance bonds
|
|
|
696
|
|
435
|
At
30 November 2024
|
|
|
696
|
|
5,038
|
|
|
|
US$'000
|
|
€'000
|
Advanced payment bonds
|
|
|
-
|
|
2,514
|
Performance bonds
|
|
|
-
|
|
499
|
At 30 November 2023
|
|
|
-
|
|
3,013
|
The advanced payment and
performance bonds are expected to expire no later than July 2026
and February 2029 respectively.
7. Contingent
assets
The Group remains in negotiation
with its insurers and FEMA in respect of damage caused by Hurricane
Helene to its operations in Hendersonville, North
Carolina. At 30 November 2024, the
Group considered that insurance proceeds of
£0.5 million were probable and intended to recognise
these in the period in which they became virtually certain.
Insurance proceeds of £0.5 million were received after the balance
sheet date and will be recognised in the year ending 30 November
2025. No insurance proceeds
have been recognised in
the year-ended 30 November 2024.
8. Cash
generated from operations
|
|
|
2024
£'000
|
|
2023
£'000
|
Operating profit
|
|
|
22,797
|
|
21,240
|
Adjustments for:
|
|
|
|
|
|
Fair value movement of derivatives
through profit and loss
|
|
|
283
|
|
(15)
|
Share-based payments
|
|
|
751
|
|
1,048
|
Depreciation of property, plant and
equipment and amortisation of intangibles
|
5,504
|
|
4,583
|
Depreciation of right-of-use
assets
|
|
|
2,201
|
|
2,232
|
Impairment of property, plant and
equipment
|
|
|
16
|
|
38
|
Loss/(gain) on disposal of
assets
|
|
|
184
|
|
(2)
|
Operating cash flows before movement in working
capital
|
|
|
31,736
|
|
29,124
|
Decrease/(increase) in
inventories
|
|
|
548
|
|
(430)
|
(Increase)/decrease in trade and
other receivables
|
|
|
(7,161)
|
|
973
|
Increase/(decrease) in trade and
other payables
|
|
|
2,876
|
|
(3,019)
|
Decrease in provisions
|
|
|
(27)
|
|
(392)
|
Increase in working
capital
|
|
|
(3,764)
|
|
(2,868)
|
Post-employment benefits
|
|
|
(2,228)
|
|
(2,177)
|
Cash generated from operations
|
|
|
25,744
|
|
24,079
|
9.
Acquisitions
On 4 December 2023, the Group
acquired 100% of the share capital of European Filter Corporation
NV ("EFC"), a filtration business based in Lummen, Belgium.
EFC has expertise in the manufacture of mist elimination filters
used in the production of industrial feedstocks and
well-established industrial filtration sales channels in north east
Europe. EFC joins the Group's Aerospace & Industrial
division, bringing complementary products and engineering as well
as strengthening European routes to market.
The acquisition completed on a cash
free, debt free basis and subject to an agreed level of working
capital. Total cash consideration of £10.3 million was paid
in the year. In the period since acquisition, EFC has
contributed £9.5 million of revenue (£9.3
million at constant currency), £1.6 million of adjusted operating
profit and £1.1 million of operating profit.
The following table sets out the
consideration paid, together with the fair value of assets acquired
and liabilities assumed:
|
|
|
Total
|
|
|
|
£'000
|
Cash consideration
|
|
|
10,294
|
Fair value of net assets acquired
(below)
|
|
|
(4,790)
|
Goodwill
|
|
|
5,504
|
|
|
|
Fair value
|
|
£'000
|
Property, plant and equipment
(including right-of-use assets)
|
1,914
|
Trademark, customer order book and
relationships (included within intangible assets)
|
4,092
|
Inventories
|
943
|
Trade and other
receivables
|
1,626
|
Cash and
cash equivalents
|
128
|
Deferred tax liability
|
(816)
|
Trade and other payables (including
lease liabilities)
|
(3,097)
|
Fair value of net assets acquired
|
|
|
4,790
|
|
|
|
|
An independent valuation of the
identifiable intangible assets has been performed. The fair
value of acquired intangible assets comprises trademarks of
£0.6 million, a customer order book of £0.2
million and customer relationships of £3.3 million.
The goodwill is attributable to
non-contractual relationships, the synergies between the business
acquired and the operations of the Group, and the potential to
develop the business acquired. None of these meet the
criteria for recognition of intangible assets separable from
goodwill. The goodwill recognised is attributable to the
Aerospace & Industrial division and is not expected to be
deductible for income tax purposes.
The fair value of trade and other
receivables of £1.6 million includes net trade receivables of £1.6
million, all of which is expected to be collectible.
A summary of remaining deferred and
contingent consideration on previous acquisitions is as
follows:
|
2024
|
|
2023
|
|
£'000
|
|
£'000
|
At 1 December
|
161
|
|
945
|
Deferred consideration
|
-
|
|
200
|
Cash paid in year
|
(38)
|
|
(1,028)
|
Unwind of discount
|
-
|
|
55
|
Exchange
|
-
|
|
(11)
|
At
30 November
|
123
|
|
161
|
|
2024
|
|
2023
|
Included within other
payables:
|
£'000
|
|
£'000
|
Current
|
38
|
|
38
|
Non-current
|
85
|
|
123
|
At
30 November
|
123
|
|
161
|
10.
Basis of
preparation
The results for the year ended 30
November 2024 have been prepared in accordance with the Companies
Act 2006 and UK-adopted International Accounting Standards.
The financial information contained in this announcement does
not constitute statutory accounts as defined in Section 434 of the
Companies Act 2006. The financial information has been
extracted from the financial statements for the year ended 30
November 2024, which have been approved by the Board of Directors
and on which the Auditors have reported without
qualification. The financial statements will be delivered to
the Registrar of Companies after the Annual General Meeting.
The financial statements for the year ended 30 November 2023, upon
which the Auditors reported without qualification, have been
delivered to the Registrar of Companies.
11. Annual general
meeting
The Company's Annual General Meeting
will be held at 11.00 a.m. on Tuesday 15 April 2025 at the offices
of Burson Buchanan, 107 Cheapside, London,
EC2V 6DN.
12. Responsibility
statement
Each of the Directors confirms, to
the best of their knowledge, that:
· the
financial statements, on which this announcement is based, have
been prepared in accordance with the
Companies Act 2006 and UK-adopted International Accounting
Standards, and give a true and fair view of
the assets, liabilities, financial position, and profit or loss of
the Company and the undertakings included in the consolidation
taken as a whole; and
· the
review of the business includes a fair review of the development
and performance of the business and the position of the Company and
the undertakings included in the consolidation taken as a whole,
together with a description of the principal risks and
uncertainties that they face.
The Directors of Porvair are listed
in the Porvair Annual Report & Accounts for the year ended 30
November 2023. Since the publication
of the Annual Report for the year ended 30 November 2023, Sarah
Vawda resigned from the Board on 2 April 2024. Sheena Mackay
joined the Board on 28 October 2024. Hooman Caman Javvi was appointed to the Board as Chief
Executive Officer designate. Hooman joined the Group on 6
January 2025 and will assume the role of Chief Executive Officer on
the retirement of Ben Stocks, following the Company's AGM on 15
April 2025. A list of current
Directors is maintained on the Porvair plc website,
www.porvair.com.
The Annual Report & Accounts for the
year ended 30 November 2024 will be made available in March 2025
on www.porvair.com.